CASE No COMP/M.3099 : Areva / Urenco / ETC JV
$9.95
12 word format
document in english
European law
law case
published 05/09/2006
review : not yet assessed
level : Advanced
requested 8 times
SummaryIn its decision of the 6th October 2004, the European Commission has assessed the compatibility with the common market of the concentration of two firms from the nuclear industry sector, following the procedure laid down in the merger regulation. This concentration was proposed by the French company, Areva (Société de participations du Commissariat à l’Energie atomique SA) and aimed at the creation of a joint venture, by a common control of ETC (Enrichment Technology Company Limited), a British undertaking which used to be wholly controlled by the British holding, Urenco Limited.
In this case, the Commission assesses the potential effects of this concentration on competition, since it raises serious doubts about the compatibility of this operation with the common market.
In order to comment this case, we will summarise the facts at stake, examine the arguments of the commission and its conclusion. We will also have a closer look at the remedies proposed before weighing the advantages and drawbacks of the Commission’s proposition.
In this case, the Commission assesses the potential effects of this concentration on competition, since it raises serious doubts about the compatibility of this operation with the common market.
In order to comment this case, we will summarise the facts at stake, examine the arguments of the commission and its conclusion. We will also have a closer look at the remedies proposed before weighing the advantages and drawbacks of the Commission’s proposition.
Table of Contents
- Summary of the facts.
- Arguments of the European Commission.
- Reasons for the decision.
- The nature of the proposed remedies.
- Advantages and disadvantages of what is proposed by the Commission.
Latest in the category European law
knowledge network